🕵️ Akari Therapeutics PLC ($AKTX)
SEC insider & ownership activity, last 12 months · CIK 1541157 · every row links its SEC filing
Insider buy value was withheld pending verification over the last 12 months. Hoyoung HUH, M.D., PH.D. added 15.5% → 18.4%; RAY Prudo, M.D. trimmed 9.3% → 8.9%. One red-flag 8-K in the window: Delisting notice (3.01), Nov 24, 2025.
Insider flow
8 buyers, value withheld pending verification (15 lots) · 0 sellers, $0 (0 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| James R. Neal | 2 | value withheld pending verification | 0 | – | Dec 16, 2025 |
| Gaslightwala Abizer | 2 | value withheld pending verification | 0 | – | Dec 16, 2025 |
| Kameel D. Farag | 1 | value withheld pending verification | 0 | – | Dec 16, 2025 |
| Robert B. Bazemore | 2 | value withheld pending verification | 0 | – | Dec 16, 2025 |
| Huh Hoyoung | 2 | value withheld pending verification | 0 | – | Dec 16, 2025 |
| Samir R. Patel | 2 | value withheld pending verification | 0 | – | Dec 16, 2025 |
| RAY Prudo, M.D. | 2 | value withheld pending verification | 0 | – | Dec 16, 2025 |
| Sandip I. Patel | 2 | value withheld pending verification | 0 | – | Dec 16, 2025 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Hoyoung HUH, M.D., PH.D. | 18.4% | 13G | Mar 4, 2026 | filing ↗ | |
| Samir R. Patel | 10.4% | 13D | Mar 2, 2026 | filing ↗ | |
| RAY Prudo, M.D. | 8.9% | 13D | Mar 2, 2026 | filing ↗ | |
| Mmcap International Inc. SPC | 8.0% | 13G | Jun 8, 2026 | filing ↗ | |
| MM Asset Management Inc. | 8.0% | 13G | Jun 8, 2026 | filing ↗ | |
| Bank of Montreal | 5.7% | 13G | Aug 12, 2026 | filing ↗ | |
| Bank of Montreal Holding Inc. | 5.7% | 13G | Aug 12, 2026 | filing ↗ | |
| BMO Nesbitt Burns Inc. | 5.7% | 13G | Aug 12, 2026 | filing ↗ | |
| White LION Capital LLC | 5.0% | 13G | Aug 7, 2026 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Earnings (2.02) | Aug 13, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 13, 2026 | filing ↗ |
| Shareholder vote (5.07) | Jun 30, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 30, 2026 | filing ↗ |
| Material agreement (1.01) | Jun 23, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 23, 2026 | filing ↗ |
| Material agreement (1.01) | May 20, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | May 20, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 20, 2026 | filing ↗ |
| Material Modifications to Rights of Security Holders (3.03) | Mar 17, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Mar 17, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 17, 2026 | filing ↗ |
| Shareholder vote (5.07) | Mar 2, 2026 | filing ↗ |
| Material agreement (1.01) | Dec 16, 2025 | filing ↗ |
| Agreement terminated (1.02) | Dec 16, 2025 | filing ↗ |
| Unregistered equity sale (3.02) | Dec 16, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Dec 16, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Dec 16, 2025 | filing ↗ |
| Shareholder vote (5.07) | Dec 15, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Dec 15, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Dec 8, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Dec 8, 2025 | filing ↗ |
| Delisting notice (3.01) | Nov 24, 2025 | filing ↗ |
| Officer/director changes (5.02) | Oct 22, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Oct 22, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Oct 15, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Oct 15, 2025 | filing ↗ |
| Material agreement (1.01) | Oct 14, 2025 | filing ↗ |
| Unregistered equity sale (3.02) | Oct 14, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Oct 14, 2025 | filing ↗ |